Literature DB >> 4601347

A review: biological and clinical aspects of pyrimidine metabolism.

R L Levine, N J Hoogenraad, N Kretchmer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4601347     DOI: 10.1203/00006450-197407000-00008

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


× No keyword cloud information.
  16 in total

Review 1.  Pyrimidine metabolism in schistosomes: A comparison with other parasites and the search for potential chemotherapeutic targets.

Authors:  Mahmoud H El Kouni
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  2017-07-21       Impact factor: 2.231

2.  Postnatal ontogeny of uridine kinase in the cerebellum, hypothalamus, and cerebral cortex of the rat.

Authors:  M Litteria; C G Popoff
Journal:  Neurochem Res       Date:  1985-01       Impact factor: 3.996

3.  Targeting dihydroorotate dehydrogenase in acute myeloid leukemia.

Authors:  Zhihong Zeng; Marina Konopleva
Journal:  Haematologica       Date:  2018-09       Impact factor: 9.941

4.  Activity of orotate metabolizing enzyme complex and various urea-cycle enzymes in mutant mice with ornithine transcarbamylase deficiency.

Authors:  I A Qureshi; J Letarte; R Ouellet
Journal:  Experientia       Date:  1982-03-15

5.  The differential susceptibility of early chick embryos to 5-bromodeoxyuridine.

Authors:  H Lee; G W Kalmus
Journal:  Experientia       Date:  1978-03-15

6.  Stimulation of the phosphorylation of uridine in skeletal muscle by insulin and vanadate.

Authors:  N Haugaard; A Torbati; T Smithgall; G Wildey
Journal:  Mol Cell Biochem       Date:  1990-03-05       Impact factor: 3.396

7.  Adverse effects of hyperbaric oxygen on [3H]uridine incorporation and uridine kinase activity in B104 rat neuroblastoma cells.

Authors:  G J Gendimenico; N Haugaard
Journal:  Mol Cell Biochem       Date:  1990-06-01       Impact factor: 3.396

Review 8.  New strategies to treat AML: novel insights into AML survival pathways and combination therapies.

Authors:  Ramya Nair; Alejandro Salinas-Illarena; Hanna-Mari Baldauf
Journal:  Leukemia       Date:  2020-10-29       Impact factor: 11.528

9.  Phase I trial of combination therapy of cancer with N-phosphonacetyl-L-aspartic acid and dipyridamole.

Authors:  M Markman; T C Chan; S Cleary; S B Howell
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

10.  Uridine-induced hypothermia in mice and rats in relation to plasma and tissue levels of uridine and its metabolites.

Authors:  G J Peters; C J van Groeningen; E J Laurensse; J Lankelma; A Leyva; H M Pinedo
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.